Načítá se...
Five-factor prognostic model for survival of post-platinum patients with metastatic urothelial carcinoma receiving PD-L1 inhibitors
PURPOSE: A prognostic model for overall survival (OS) of post-platinum patients with metastatic urothelial carcinoma (mUC) receiving PD-1/PD-L1 inhibitors is necessary since existing models were constructed in the chemotherapy setting. MATERIALS AND METHODS: Patient level data were used from phase I...
Uloženo v:
| Vydáno v: | J Urol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7655635/ https://ncbi.nlm.nih.gov/pubmed/32552295 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JU.0000000000001199 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|